Skip to main content
. 2023 Feb 24;9(3):e13763. doi: 10.1016/j.heliyon.2023.e13763

Table 2a.

Mention of drug indications in primary outcomes

Drug indications Heparin Rivaroxaban Apixaban Edoxaban Dabigatran Warfarin
Thrombosis 27 6 2 0 1 0
Deep vein thrombosis 5 0 1 0 0 0
Pulmonary thrombosis 0 0 0 0 0 0
Pulmonary embolism 12 2 2 0 1 0
Hypercoagulation 0 0 0 0 0 0
Acute myocardial infarction 6 3 1 0 1 0
Embolism venous 0 0 0 0 0 0
Pulmonary thromboembolism 0 0 0 0 0 0
Embolism 7 2 2 0 2 0
Venous thrombosis 7 2 0 0 0 0